1. Suppressive effect of isofraxidin on the overexpression of IL-6 and its molecular mechanism in a TPA-treated human hepatocellular carcinoma cell line, HuH-7
   Taisuke Yamazaki et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. Effect of isolated grandivittin from Ferulago trifida Boiss. (Apiaceae) on the proliferation and apoptosis of human lung cancer A549 cells
   Fatemeh Zomorodi Anbaji et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
3. New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story
   Ibrahim H. Eissa et al, 2023, Journal of Molecular Structure CrossRef
4. Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy
   Yifan Liu et al, 2023, Cancer Nanotechnology CrossRef
5. Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer
   Kiran S. Patil et al, 2023, Journal of Pharmaceutical Innovation CrossRef
6. Metabolic profiling of Chimonanthus grammatus via UHPLC-HRMS-MS with computer-assisted structure elucidation and its antimicrobial activity
   Haibo Hu et al, 2023, Frontiers in Plant Science CrossRef
7. The multifaceted roles of matrix metalloproteinases in lung cancer
   Cui Wei, 2023, Frontiers in Oncology CrossRef
8. Thymoquinone‐induced antitumor and apoptosis in human lung adenocarcinoma cells
   Saeed Samarghandian et al, 2019, Journal of Cellular Physiology CrossRef
9. Isofraxidin exerts anti-diabetic, antilipidemic, and antioxidant effects and protects renal tissues via inhibition of NF-ĸB in Streptozotocin-induced diabetic rats
   Wei Lu et al, 2022, Molecular & Cellular Toxicology CrossRef